Skip to content

The effects of different doses of oxycodone combined with propofol on hysteroscopy

The effects of different doses of oxycodone combined with propofol on hysteroscopy, A prospective, double blind randomized study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPD-17013134
Enrollment
Unknown
Registered
2017-10-28
Start date
2015-08-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hysteroscopy

Interventions

Sponsors

The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II ;Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II ;Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II ;Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II ;Inclusion criteria: Scheduled for the patients who undergone hysteroscopy, aged 20 to 52 years old, BMI in 17 ~ 27 kg/m2, ASA I-II

Exclusion criteria

Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded. ;Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded. ;Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded. ;Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded. ;Exclusion criteria: Patients with a history of severity heart and lung diseases, psychiatric disease, allergy or hypersensitivity to local anesthetics and long-term administration of analgesics were excluded.

Design outcomes

Primary

MeasureTime frame
Propofol induced dosage;Propofol maintenance dosage;Propofol total dosage;total propofol administration time;the consumption of propofol per minute;operation time;operation time;body movement;emergence time;discharge time;occurrence of adverse cardiovascular events;hypoxemia;adverse reactions;visual analogue scale;blood pressure;heart rate;pulse oxygen saturation;

Countries

China

Contacts

Public ContactHan Lin;Han Lin;Han Lin;Han Lin;Han Lin ;;;;

Wenzhou People's Hospital;Wenzhou People's Hospital;Wenzhou People's Hospital;Wenzhou People's Hospital;Wenzhou People's Hospital

nanlinhannansh@qq.com;nanlinhannansh@qq.com;nanlinhannansh@qq.com;nanlinhannansh@qq.com;nanlinhannansh@qq.com+86 15868710831;+86 15868710831;+86 15868710831;+86 15868710831;+86 15868710831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026